Leading Jerusalem hospital Shaare Zedek Medical Center has partnered with international investment firm Arieli Capital to create a joint healthcare innovation hub.
The Shaare Zedek Arieli Innovation Hub (SHAAR) is designed to be a center for medical research. The two say Arieli’s investment expertise will be leveraged to support startups and cutting-edge medical innovation there, turning “visionary healthcare ideas into impactful solutions.”
SHAAR intends to announce an open call for companies to join its first scale-up cohort by the end of 2023. The emphasis will be on healthcare startups that are ready for the global market.
“SHAAR, Hebrew for Gateway, is a true embodiment of our mission,” said Shaare Zedek CEO Prof. Ofer Merin.
“Our goal is to equip entrepreneurs with direct access to physicians, clinical settings, data and samples. Such access is essential, serving as a springboard for the development of innovative medical solutions. I have no doubt that this significant partnership with Arieli Capital, led by Prof. Dan Turner and Dr. Renana Ofan, will greatly contribute to the success of this initiative,” he said.
“We are honored to partner with the Shaare Zedek Medical Center to bring the important mission of SHAAR to life,” said Evan Renov, Co-Founder and Chief Executive Officer of Arieli.
“We are eager to bring Arieli’s global business expertise in growing healthcare startups to SHAAR. Our goal is to bridge the gap between promising entrepreneurs and the venture capital industry, ultimately impacting people’s lives and healthcare on a global scale.”
Facebook comments